235 related articles for article (PubMed ID: 14530624)
1. Therapy with intravenous immunoglobulins: complications and side-effects.
Wittstock M; Benecke R; Zettl UK
Eur Neurol; 2003; 50(3):172-5. PubMed ID: 14530624
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.
Wittstock M; Zettl UK
J Neurol; 2006 Sep; 253 Suppl 5():V75-9. PubMed ID: 16998759
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
Dalakas MC
JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immune globulin therapy for neurologic diseases.
Dalakas MC
Ann Intern Med; 1997 May; 126(9):721-30. PubMed ID: 9139559
[TBL] [Abstract][Full Text] [Related]
5. Side effects of intravenous immunoglobulins in neurological autoimmune disorders--a prospective study.
Stangel M; Kiefer R; Pette M; Smolka MN; Marx P; Gold R
J Neurol; 2003 Jul; 250(7):818-21. PubMed ID: 12883923
[TBL] [Abstract][Full Text] [Related]
6. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
[TBL] [Abstract][Full Text] [Related]
7. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology?
Elovaara I; Hietaharju A
Acta Neurol Scand; 2010 Nov; 122(5):309-15. PubMed ID: 20085560
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin treatment of neurological autoimmune diseases.
Stangel M; Hartung HP; Marx P; Gold R
J Neurol Sci; 1998 Jan; 153(2):203-14. PubMed ID: 9511879
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
[TBL] [Abstract][Full Text] [Related]
10. Clinical applications of intravenous immunoglobulins in neurology.
Hughes RA; Dalakas MC; Cornblath DR; Latov N; Weksler ME; Relkin N
Clin Exp Immunol; 2009 Dec; 158 Suppl 1(Suppl 1):34-42. PubMed ID: 19883422
[TBL] [Abstract][Full Text] [Related]
11. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
[TBL] [Abstract][Full Text] [Related]
12. Significant dermatological side effects of intravenous immunoglobulin.
Hurelbrink CB; Spies JM; Yiannikas C
J Clin Neurosci; 2013 Aug; 20(8):1114-6. PubMed ID: 23659929
[TBL] [Abstract][Full Text] [Related]
13. [Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].
Bembeeva RT; Zavadenko NN
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):83-93. PubMed ID: 26356621
[TBL] [Abstract][Full Text] [Related]
14. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
Dalakas MC
Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
[TBL] [Abstract][Full Text] [Related]
15. Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee.
Tavee J; Brannagan TH; Lenihan MW; Muppidi S; Kellermeyer L; D Donofrio P;
Muscle Nerve; 2023 Oct; 68(4):356-374. PubMed ID: 37432872
[TBL] [Abstract][Full Text] [Related]
16. Guidelines on the use of intravenous immune globulin for neurologic conditions.
Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
[TBL] [Abstract][Full Text] [Related]
17. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
Molnár MJ
Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
[TBL] [Abstract][Full Text] [Related]
18. Advances in the use of IVIg in neurological disorders.
Hughes R
J Neurol; 2008 Jul; 255 Suppl 3():1-2. PubMed ID: 18685918
[No Abstract] [Full Text] [Related]
19. Complications of intravenous immune globulin treatment in neurologic disease.
Brannagan TH; Nagle KJ; Lange DJ; Rowland LP
Neurology; 1996 Sep; 47(3):674-7. PubMed ID: 8797463
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin use for neurologic diseases.
Koski CL; Patterson JV
J Infus Nurs; 2006; 29(3 Suppl):S21-8. PubMed ID: 16878852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
